Companies

Ridge Biotechnologies

ridgebio.com

AI-enabled platform pioneering precision enzyme and targeted drug design to power precision medicines.

Employees11-50
Funding$25M
Revenue<$5M
Healthcare AIAI ApplicationB2B SaaSSeed$10M-$50M

About

Ridge Biotechnologies uses proprietary machine learning models and cell-free datasets to design precision enzymes and targeted delivery systems for precision medicines. The company targets drug developers, providing a platform that enables differentiation through improved manufacturing and therapeutic indices. They focus on next-generation bioconjugates, protein design, and enzymatic therapeutics.

Active Roles

0

No active roles right now.

Get notified when they post

Key Investors

Sutter Hill Ventures, Overlap Holdings